Novi-Beograd, Serbia Clinical Trials

A listing of Novi-Beograd, Serbia clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)

fingolimod
interferon
MRI
Novartis Investigative Site
 (3.7 away) Contact site
  • 72 views
  • 22 May, 2021
  • +99 other locations
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis Post Polycythemia Vera Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia (platelet count <50,000/L). Approximately 348 patients in total will be enrolled, randomized 2:1 to either pacritinib (approximately 232 patients) or …

pacritinib
thrombocytopenia
neutrophil count
ruxolitinib
direct bilirubin
Clinical Center of Serbia, Clinic of Hematology
 (3.7 away) Contact site
  • 506 views
  • 19 Jul, 2021
  • +177 other locations
Study to Gather Information on Safety and Use of High Dose Aflibercept Injection Into the Eye in Patients With an Age Related Eye Disorder That Causes Blurred Vision or a Blind Spot Due to Abnormal Blood Vessels That Leak Fluid Into the Light Sensitive Lining Inside the Eye

In this study researchers want to learn more about changes in visual acuity (clarity of vision) with a high dose treatment with Aflibercept (Eylea) in patients suffering from neovascular age-related macular degeneration (nAMD). Neovascular AMD is an eye disease that causes blurred vision or a blind spot due to abnormal …

Clinical Center Nis
 (2.7 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +309 other locations
Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary Disease (COPD) as measured by Annualized rate of acute moderate or severe COPD exacerbation (AECOPD) Secondary Objectives: To evaluate the effect of dupilumab administered every 2 weeks on Pre-bronchodilator …

bronchodilator
eosinophil count
cough
muscarinic antagonists
dyspnea
Investigational Site Number 6880007
 (3.7 away) Contact site
  • 156 views
  • 18 Jul, 2021
  • +217 other locations
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

crohn's disease
Clinical Center Bezanijska Kosa
 (3.7 away) Contact site
  • 22 views
  • 24 Jul, 2021
  • +301 other locations
Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to assess the efficacy of etrasimod on clinical remission in participants with moderately to severely active ulcerative colitis (UC).

endoscopy
remission
Clinical Center " Dr Dragisa Misovic Dedinje"
 (3.7 away) Contact site
  • 12 views
  • 01 Aug, 2021
  • +438 other locations
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

The purpose of the study is to evaluate the effect of macitentan 75 mg versus placebo on exercise capacity at Week 28 in participants with chronic thromboembolic pulmonary hypertension (CTEPH).

macitentan
Clinical Center of Serbia
 (3.7 away) Contact site
  • 17 views
  • 16 Jul, 2021
  • +177 other locations
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Patients With Severe Hemophilia A or B

Treatment with PF-06741086 is anticipated to demonstrate a clinically relevant advantage and/or a major contribution to patient care in comparison to current methods of treatment for hemophilia A or B because it works differently than factor replacement products and will work in the presence of inhibitors. The potential for once …

hemophilia
coagulation factor
Factor VIII
acute bleeding
treatment regimen
Clinical Center of Serbia
 (3.7 away) Contact site
  • 58 views
  • 14 Jul, 2021
  • +74 other locations
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).

lupus
Clinical Center of Serbia
 (3.7 away) Contact site
  • 503 views
  • 31 Jul, 2021
  • +556 other locations
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

The purpose of the MycarinGstudy is to demonstrate the clinical efficacy and to assess safety and tolerability of rozanolixizumab in patients with generalized myasthenia gravis (MG).

immune globulin
rozanolixizumab
acetylcholine
generalized myasthenia gravis
plasma exchange
Mg0003 40468
 (4.0 away) Contact site
  • 76 views
  • 01 Aug, 2021
  • +130 other locations